Cellectis (CLLS) Short Interest Ratio & Short Volume $1.48 -0.03 (-1.99%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Cellectis Short Interest DataCellectis (CLLS) has a short interest of 203,500 shares. This marks a 59.73% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 184,051 shares to cover all short positions.Current Short Interest203,500 sharesPrevious Short Interest127,400 sharesChange Vs. Previous Month+59.73%Dollar Volume Sold Short$366,300.00Short Interest Ratio1.9 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares55,584,000 sharesPercentage of Shares Shorted0.37%Today's Trading Volume213,838 sharesAverage Trading Volume184,051 sharesToday's Volume Vs. Average116% Short Selling Cellectis? Sign up to receive the latest short interest report for Cellectis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLLS Short Interest Over TimeCLLS Days to Cover Over TimeCLLS Percentage of Float Shorted Over Time Cellectis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/2024203,500 shares $366,300.00 +59.7%N/A1.9 $1.80 12/15/2024127,400 shares $224,224.00 -3.0%N/A2.1 $1.76 11/30/2024131,400 shares $275,940.00 -6.5%N/A2.3 $2.10 11/15/2024140,500 shares $262,735.00 -10.1%N/A2.7 $1.87 10/31/2024156,200 shares $278,036.00 -55.0%N/A3.6 $1.78 10/15/2024346,800 shares $658,920.00 -2.6%N/A7.6 $1.90 9/30/2024356,100 shares $762,054.00 -2.1%N/A8.5 $2.14 9/15/2024363,600 shares $818,100.00 -4.9%N/A8.4 $2.25 8/31/2024382,400 shares $917,760.00 -3.3%N/A7.1 $2.40 8/15/2024395,400 shares $806,616.00 -10.3%N/A7.4 $2.04 Get the Latest News and Ratings for CLLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024440,700 shares $973,947.00 -0.5%N/A8 $2.21 7/15/2024443,100 shares $926,079.00 +1.4%N/A8.1 $2.09 6/30/2024436,800 shares $816,816.00 +4.5%N/A7.8 $1.87 6/15/2024418,200 shares $940,950.00 -1.4%N/A7.5 $2.25 5/31/2024424,200 shares $1.15 million -16.8%N/A9.1 $2.71 5/15/2024509,900 shares $1.57 million -22.3%N/A9.9 $3.08 4/30/2024656,100 shares $1.68 million -2.5%N/A12.9 $2.56 4/15/2024672,800 shares $1.76 million -0.6%N/A17.8 $2.62 3/31/2024676,500 shares $1.79 million -0.4%N/A16.3 $2.65 3/15/2024679,300 shares $1.73 million -6.6%N/A13.5 $2.54 2/29/2024727,500 shares $1.88 million -0.1%N/A10.6 $2.58 2/15/2024728,200 shares $2.08 million -0.9%N/A8.2 $2.85 1/31/2024735,100 shares $2.21 million -4.2%N/A3.6 $3.00 1/15/2024767,300 shares $2.22 million -1.9%N/A0.4 $2.89 12/31/2023781,800 shares $2.41 million -7.0%N/A0.4 $3.08 12/15/2023840,900 shares $2.69 million -19.9%N/A0.5 $3.20 11/30/20231,050,000 shares $3.13 million -28.1%N/A0.6 $2.98 11/15/20231,460,000 shares $4.09 million +302.8%N/A0.8 $2.80 10/31/2023362,500 shares $349,450.00 -2.7%N/A0.2 $0.96 10/15/2023372,400 shares $513,912.00 +7.9%N/A6.9 $1.38 9/30/2023345,200 shares $545,416.00 +7.6%N/A5.6 $1.58 9/15/2023320,800 shares $545,360.00 -0.5%N/A6.3 $1.70 8/31/2023322,300 shares $667,161.00 -2.7%N/A6.5 $2.07 8/15/2023331,100 shares $652,267.00 -3.5%N/A6.5 $1.97 7/31/2023343,200 shares $734,448.00 +9.2%N/A5.7 $2.14 7/15/2023314,400 shares $704,287.44 +0.5%N/A5.5 $2.24 6/30/2023312,800 shares $615,434.00 -1.4%N/A6.2 $1.97 6/15/2023317,300 shares $640,946.00 +2.6%N/A5.2 $2.02 5/31/2023309,200 shares $587,480.00 -2.5%N/A4.5 $1.90 5/15/2023317,200 shares $558,272.00 +0.2%N/A4.6 $1.76Grab This Altcoin Before Trump's Crypto Announcement (Ad)Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now. Click here to check it out now 4/30/2023316,700 shares $595,396.00 -13.0%N/A3.7 $1.88 4/15/2023363,800 shares $742,152.00 -0.2%N/A3.2 $2.04 3/31/2023364,600 shares $703,678.00 -2.3%N/A2.8 $1.93 3/15/2023373,100 shares $682,773.00 +1.4%N/A2.7 $1.83 2/28/2023367,900 shares $813,059.00 -6.6%N/A2.5 $2.21 2/15/2023393,800 shares $945,120.00 +5.4%N/A2.6 $2.40 1/31/2023373,600 shares $1.14 million +34.6%N/A2.4 $3.05 1/15/2023277,600 shares $1.07 million +31.0%0.6%2.4 $3.84 12/30/2022211,900 shares $444,990.00 -32.2%0.5%1.9 $2.10 12/15/2022312,400 shares $702,900.00 -17.4%0.7%3.2 $2.25 11/30/2022378,000 shares $831,600.00 -28.2%0.8%4.5 $2.20 11/15/2022526,300 shares $1.18 million -9.3%1.2%6.3 $2.25 10/31/2022580,400 shares $1.44 million -13.9%1.3%6.9 $2.49 10/15/2022674,400 shares $1.66 million -6.7%1.5%6.5 $2.46 9/30/2022722,600 shares $1.65 million -11.8%1.6%6.6 $2.29 9/15/2022819,400 shares $2.61 million -2.4%1.8%7.2 $3.19 8/31/2022839,700 shares $2.78 million -2.4%1.9%6.5 $3.31 8/15/2022860,300 shares $3.51 million -3.0%1.9%6.3 $4.08 7/31/2022887,300 shares $2.32 million -9.2%2.0%6.1 $2.62 7/15/2022976,800 shares $2.40 million +1.0%2.2%6.7 $2.46 6/30/2022966,900 shares $2.74 million -4.3%2.2%6.7 $2.83 6/15/20221,010,000 shares $2.53 million -2.9%2.2%6.7 $2.50 5/31/20221,040,000 shares $3.76 million -1.9%2.3%5.2 $3.62 5/15/20221,060,000 shares $3.36 million -12.4%2.4%4.4 $3.17 4/30/20221,210,000 shares $4.24 million -24.8%2.7%4.7 $3.50 4/15/20221,610,000 shares $6.65 million -5.9%3.6%5.8 $4.13 3/31/20221,710,000 shares $7.76 million -4.5%3.8%5.5 $4.54 3/15/20221,790,000 shares $7.59 million -8.2%4.0%5.8 $4.24 2/28/20221,950,000 shares $8.83 million +18.9%4.3%6.5 $4.53 2/15/20221,640,000 shares $9.18 million +46.4%3.6%6.4 $5.60 1/31/20221,120,000 shares $6.96 million +16.7%2.5%4.6 $6.21 1/15/2022959,700 shares $7.00 million +31.4%N/A4.4 $7.29 12/31/2021730,200 shares $5.93 million +9.4%1.6%3.3 $8.12 12/15/2021667,300 shares $5.61 million -7.7%1.5%2.9 $8.41 11/30/2021722,900 shares $6.23 million +17.9%1.6%3.4 $8.62 11/15/2021613,200 shares $6.12 million +2.6%1.4%3.1 $9.98 10/29/2021597,800 shares $6.43 million -38.0%1.3%3 $10.76 10/15/2021964,500 shares $10.45 million -22.8%2.1%4.9 $10.83 9/30/20211,250,000 shares $15.76 million -1.6%2.8%6.7 $12.61 9/15/20211,270,000 shares $17.78 million +1.6%2.8%7.6 $14.00 8/31/20211,250,000 shares $17.98 million -3.9%2.8%6.7 $14.38 8/13/20211,300,000 shares $16.28 million -7.8%2.9%6.2 $12.52 7/30/20211,410,000 shares $18.26 million No Change3.1%6.5 $12.95 7/15/20211,410,000 shares $19.29 million +11.9%3.1%6.4 $13.68 6/30/20211,260,000 shares $19.49 million +5.9%2.8%5.6 $15.47 6/15/20211,190,000 shares $17.92 million -21.7%2.6%4.5 $15.06 5/28/20211,520,000 shares $23.82 million +2.7%3.4%5.4 $15.67 5/14/20211,480,000 shares $21.93 million +28.7%N/A4.5 $14.82 4/30/20211,150,000 shares $21.76 million -0.9%2.8%3.2 $18.92 4/15/20211,160,000 shares $22.63 million -5.7%2.8%2.9 $19.51Grab This Altcoin Before Trump's Crypto Announcement (Ad)Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now. Click here to check it out now 3/31/20211,230,000 shares $23.14 million +10.8%3.2%2.7 $18.81 3/15/20211,110,000 shares $22.14 million +28.1%2.9%2.4 $19.95 2/26/2021866,800 shares $17.89 million +117.8%2.2%1.7 $20.64 2/12/2021398,000 shares $10.70 million -9.3%1.0%0.9 $26.88 1/29/2021438,700 shares $12.39 million -28.6%1.0%1 $28.25 1/15/2021614,200 shares $19.00 million -21.5%1.5%1.7 $30.94 12/31/2020782,100 shares $23.00 million -10.9%1.9%2.3 $29.41 12/15/2020878,100 shares $27.41 million -3.6%2.1%3.1 $31.21 11/30/2020911,200 shares $22.06 million -10.7%2.2%4.6 $24.21 11/15/20201,020,000 shares $19.50 million +20.8%2.4%5.8 $19.12 10/30/2020844,700 shares $13.82 million +16.8%2.0%4.9 $16.36 10/15/2020723,400 shares $15.86 million +28.2%1.7%4.5 $21.92 9/30/2020564,200 shares $10.44 million -0.5%1.3%3.7 $18.50 9/15/2020567,100 shares $11.44 million +4.8%1.3%3.7 $20.18 8/31/2020540,900 shares $9.98 million +18.4%1.3%3.2 $18.45 8/14/2020456,800 shares $7.82 million +32.1%1.1%2.4 $17.12 7/31/2020345,700 shares $5.43 million -0.1%0.8%1.6 $15.70 7/15/2020345,900 shares $6.15 million -3.7%0.8%1.6 $17.77 6/30/2020359,300 shares $6.45 million +39.9%0.9%1.7 $17.94 6/15/2020256,900 shares $4.20 million -16.9%0.6%1.2 $16.34 5/29/2020309,200 shares $5.71 million -8.0%0.7%1.6 $18.47 5/15/2020336,000 shares $6.49 million -5.8%0.8%1.9 $19.32 4/30/2020356,700 shares $4.65 million +34.4%0.8%2.4 $13.05 4/15/2020265,400 shares $2.89 million +21.2%0.6%1.8 $10.89 3/31/2020218,900 shares $2.64 million -35.3%0.5%1.6 $12.06 3/13/2020338,500 shares $3.28 million +5.7%0.8%2.6 $9.70 2/28/2020320,200 shares $2.50 million +13.0%0.8%2.3 $7.81 2/14/2020283,300 shares $3.52 million +8.2%0.7%2.2 $12.42 1/31/2020261,800 shares $4.38 million +15.4%0.6%2 $16.74 CLLS Short Interest - Frequently Asked Questions What is Cellectis' current short interest? Short interest is the volume of Cellectis shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 203,500 shares of CLLS short. Learn More on Cellectis' current short interest. What is a good short interest ratio for Cellectis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLLS shares currently have a short interest ratio of 2.0. Learn More on Cellectis's short interest ratio. Is Cellectis' short interest increasing or decreasing? Cellectis saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 203,500 shares, an increase of 59.7% from the previous total of 127,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cellectis' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cellectis: Organogenesis Holdings Inc. (15.41%), Aura Biosciences, Inc. (2.85%), KalVista Pharmaceuticals, Inc. (15.08%), Neumora Therapeutics, Inc. (23.55%), Eton Pharmaceuticals, Inc. (0.94%), Valneva SE (0.02%), enGene Holdings Inc. (0.33%), Revance Therapeutics, Inc. (7.99%), Korro Bio, Inc. (11.74%), Monte Rosa Therapeutics, Inc. (19.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Cellectis stock? Short selling CLLS is an investing strategy that aims to generate trading profit from Cellectis as its price is falling. CLLS shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cellectis? A short squeeze for Cellectis occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLLS, which in turn drives the price of the stock up even further. How often is Cellectis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLLS, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies Organogenesis Short Interest Aura Biosciences Short Interest KalVista Pharmaceuticals Short Interest Neumora Therapeutics Short Interest Eton Pharmaceuticals Short Interest Valneva Short Interest enGene Short Interest Revance Therapeutics Short Interest Korro Bio Short Interest Monte Rosa Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLLS) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
